Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIN
12151
Aberdeen Intermediate Income Fund
MIN
$282M
| $30.8K | ﹤0.01% |
+11,596
| New | +$30.4K |
|
12152
CALL
Apyx Medical
APYX
$128M
| $30.8K | ﹤0.01% |
23,000
+7,000
| +44% | +$10.3K |
|
12153
CALL
Talkspace
TALK
$871M
| $30.8K | ﹤0.01% |
13,400
+11,200
| +509% | +$32.2K |
|
12154
PUT
Ultralife
ULBI
$125M
| $30.8K | ﹤0.01% |
2,900
-9,100
| -76% | -$96.9K |
|
|
AVX
12155
Avax One Technology Ltd
AVX
$23.6M
| $30.8K | ﹤0.01% |
+32
| New | +$43.5K |
|
12156
CALL
Galectin Therapeutics
GALT
$347M
| $30.7K | ﹤0.01% |
13,600
+5,900
| +77% | +$17.9K |
|
12157
CALL
GraniteShares 2x Short NVDA Daily ETF
NVD
$48.6M
| $30.7K | ﹤0.01% |
556
-136
| -20% | -$13.7K |
|
12158
CALL
WesBanco
WSBC
$4.09B
| $30.7K | ﹤0.01% |
1,100
-1,000
| -48% | -$27.6K |
|
|
12159
PUT
WesBanco
WSBC
$4.09B
| $30.7K | ﹤0.01% |
1,100
+100
| +10% | +$2.77K |
|
12160
PUT
Heritage Financial
HFWA
$1.22B
| $30.7K | ﹤0.01% |
1,700
+1,000
| +143% | +$17.9K |
|
12161
Abits Group
ABTS
$4.24M
| $30.6K | ﹤0.01% |
3,697
+3,250
| +727% | +$33.1K |
|
12162
PUT
Good Times Restaurants
GTIM
$16.4M
| $30.6K | ﹤0.01% |
12,100
+3,300
| +38% | +$8.6K |
|
12163
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$19.8M
| $30.6K | ﹤0.01% |
+40
| New | +$31.6K |
|
12164
PUT
ProShares UltraShort Silver
ZSL
$58M
| $30.6K | ﹤0.01% |
68
-87
| -56% | -$42.6K |
|
|
PMD
12165
DELISTED
Psychemedics Corporation
PMD
| $30.6K | ﹤0.01% |
12,640
-5,316
| -30% | -$13.5K |
|
|
MTLS
12166
CALL
Materialise
MTLS
$400M
| $30.6K | ﹤0.01% |
6,100
-6,900
| -53% | -$35.5K |
|
12167
PUT
Solid Power
SLDP
$552M
| $30.5K | ﹤0.01% |
18,500
-1,800
| -9% | -$3.11K |
|
12168
ProQR Therapeutics
PRQR
$271M
| $30.5K | ﹤0.01% |
18,365
-27,643
| -60% | -$53.7K |
|
12169
PUT
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
| $30.5K | ﹤0.01% |
1,400
+800
| +133% | +$17.6K |
|
12170
CALL
Neumora Therapeutics
NMRA
$301M
| $30.5K | ﹤0.01% |
3,100
-1,400
| -31% | -$14.5K |
|
12171
CALL
Century Casinos
CNTY
$36M
| $30.5K | ﹤0.01% |
11,000
+1,900
| +21% | +$5.51K |
|
12172
CALL
Adaptive Biotechnologies
ADPT
$3.94B
| $30.4K | ﹤0.01% |
8,400
+5,800
| +223% | +$18.4K |
|
12173
Larimar Therapeutics
LRMR
$453M
| $30.4K | ﹤0.01% |
4,189
-1,160,070
| -100% | -$8.88M |
|
|
RGLS
12174
CALL
DELISTED
Regulus Therapeutics
RGLS
| $30.3K | ﹤0.01% |
17,000
-9,200
| -35% | -$21.4K |
|
12175
PUT
Latham Group
SWIM
$861M
| $30.3K | ﹤0.01% |
10,000
+2,800
| +39% | +$9.76K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.